Log In
Print
BCIQ
Print
Print this Print this
 

CLP-1001

  Manage Alerts
Collapse Summary General Information
Company Sorbent Therapeutics Inc.
DescriptionOral non-absorbed fluid and sodium binder
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat fluid overload in patients with heart failure; Treat heart failure; Treat heart failure in patients with chronic kidney disease (CKD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today